Experts from different branches of medicine in the country will present the results of the application of the product of Cuban biotechnology, Hebervital, in a national workshop that will take place today in this city, announced the organizing committee.
The National Center for Minimal Access Surgery (CNCMA by its Spanish acronym) first in Cuba of this branch of medicine, made more than 4,500 such surgical procedures in 2016, with very good results, announced the director of that institution
With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world
Radio Rebelde. 23 # 258 % L y M. Vedado. Plaza de la Revolucion Havana City, Cuba CP. 10400.
Webmaster: Yirian García de la Torre. Journalist: Liannis Mateu Francés
- Malvy Souto López - Ruth Soto Falcón.
Photojournalist: Abel Rojas Barallobre. Programmer: Mabel Peña Soutuyo. Developed by
Radio Rebelde Web Team